Metformin use mitigates the adverse prognostic effect of diabetes mellitus in chronic obstructive pulmonary disease
Abstract Background and objective Among patients with chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM) is a common comorbidity and is probably associated with increased systemic inflammation and worse prognosis. Metformin, with its pleiotropic anti-inflammatory and antioxidant ac...
Main Authors: | Te-Wei Ho, Chun-Ta Huang, Yi-Ju Tsai, Angela Shin-Yu Lien, Feipei Lai, Chong-Jen Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-04-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-019-1035-9 |
Similar Items
-
Effects and safety of metformin in patients with concurrent diabetes mellitus and chronic obstructive pulmonary disease: a systematic review and meta-analysis
by: Ziting Liang, et al.
Published: (2022-08-01) -
Metformin modulates immune cell infiltration into the kidney during unilateral ureteral obstruction in mice
by: Michael Christensen, et al.
Published: (2019-07-01) -
Metformin Effectiveness in Reducing Mortality among Covid-19 Patients with Type 2 Diabetes Mellitus at a Tertiary Hospital in Indonesia
by: Yudivaniel Zihono, et al.
Published: (2023-09-01) -
Effects of metformin on glucose metabolism and mitochondrial function in patients with obstructive sleep apnea: A pilot randomized trial
by: Elizabeth R. M. Zunica, et al.
Published: (2024-02-01) -
Cognitive Function in Type 2 Diabetes Mellitus Patients Taking Metformin and Metformin-Sulfonylurea
by: Abu Rachman, et al.
Published: (2022-11-01)